The effect of Duffy antigen receptor for chemokines on severity in sickle cell disease

Haematologica

Volumn 98, Issue 8, 2013, Pages

  Drasar, Emma R ^a,b   Menzel, Stephan ^a   Fulford, Tony ^c   Thein, Swee Lay ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Duffy antigen receptor for chemokines; Sickle cell disease

Indexed keywords

CHEMOKINE; CREATININE; CYSTATIN C; DUFFY BINDING PROTEIN; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; BLOOD GROUP DUFFY SYSTEM; CELL SURFACE RECEPTOR; DARC PROTEIN, HUMAN;

ADULT; ALLELE; DISEASE MARKER; DISEASE SEVERITY; ERYTHROCYTE COUNT; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; LETTER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NEUTROPHIL COUNT; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; AGED; ANEMIA, SICKLE CELL; BLOOD; BLOOD GROUP DUFFY SYSTEM; COHORT ANALYSIS; COMPLICATION; LEG ULCER; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

DUFFY ANTIGEN RECEPTOR FOR CHEMOKINES; SICKLE CELL DISEASE;

ADOLESCENT; ADULT; AGED; ANEMIA, SICKLE CELL; COHORT STUDIES; DUFFY BLOOD-GROUP SYSTEM; FEMALE; HUMANS; LEG ULCER; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

MLCS; MLOWN;

EID: 84880969948     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.089243     Document Type: Letter

References (15)

1. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639-44.
2. Thein SL. Genetic modifiers of the beta-haemoglobinopathies. Br J Haematol. 2008;141(3):357-66.
3. Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr. 1992;120(3):360-6.
4. Reich D, Nalls MA, Kao WH, Akylbekova EL, Tandon A, Patterson N, et al. Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS Genet. 2009;5(1):e1000360.
5. Afenyi-Annan A, Kail M, Combs MR, Orringer EP, Ashley-Koch A, Telen MJ. Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease. Transfusion. 2008;48(5):917-24.
6. Nalls MA, Wilson JG, Patterson NJ, Tandon A, Zmuda JM, Huntsman S, et al. Admixture mapping of white cell count: genetic locus responsible for lower white blood cell count in the Health ABC and Jackson Heart studies. Am J Hum Genet. 2008;82(1):81-7.
7. Grann VR, Ziv E, Joseph CK, Neugut AI, Wei Y, Jacobson JS, et al. Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. Br J Haematol. 2008;143(2):288-93.
8. Mecabo G, Hayashida DY, Azevedo-Shimmoto MM, Vicari P, Arruda MM, Bordin JO, et al. Duffy-negative is associated with hemolytic phenotype of sickle cell anemia. Clin Immunol. 2010;136(3):458-9; author reply 60-1.
9. Schnog JB, Keli SO, Pieters RA, Rojer RA, Duits AJ. Duffy phenotype does not influence the clinical severity of sickle cell disease. Clin Immunol. 2000;96(3):264-8.
10. Nebor D, Durpes MC, Mougenel D, Mukisi-Mukaza M, Elion J, Hardy-Dessources MD, et al. Association between Duffy antigen receptor for chemokines expression and levels of inflammation markers in sickle cell anemia patients. Clin Immunol. 2010;136 (1):116-22.
11. Ballas SK, Lieff S, Benjamin LJ, Dampier CD, Heeney MM, Hoppe C, et al. Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol. 2010;85(1):6-13.
12. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 2003;18(10):2024-31.
13. National Institute for Health and Clinical Excellence. Chronic kidney disease: Early intervention and management of chronic kidney disease in adults in primary and secondary care. London; NICE; 2008. pp. 1-36.
14. Clare A, FitzHenley M, Harris J, Hambleton I, Serjeant GR. Chronic leg ulceration in homozygous sickle cell disease: the role of venous incompetence. Br J Haematol. 2002;119(2):567-71.
15. Serjeant GR. Leg ulceration in sickle cell anemia. Arch Intern Med. 1974;133(4):690-4.